Fluent in Healthcare

Why CMS Strategy Fluency Is Becoming Essential for Companies Selling to Hospitals

Many organizations that sell into hospitals invest heavily in training their commercial teams.

Sales professionals learn product science. They understand clinical evidence, competitive differentiation, and the operational workflows their solutions support. They often spend years building expertise within specific service lines or therapeutic categories.

These investments are important and necessary.

But in the hospital market today, there is another capability that is becoming equally important.

Fluency in how hospitals actually make decisions.

Hospitals do not evaluate vendors based solely on product capability. They evaluate solutions within the context of reimbursement, federal policy, margin pressure, and quality performance.

Those forces shape how hospitals allocate capital, prioritize initiatives, and evaluate vendor partnerships.

When commercial teams understand that environment, their conversations with hospitals change in meaningful ways.

They begin discussions where hospital leaders actually make decisions.

That difference is what I call Fluent in Healthcare.

The CMS Strategy Gap

Many healthcare commercial teams are highly capable.

They understand their products. They know their customers. They work in one of the most complex markets in the economy and successfully navigate clinical, operational, and technical discussions every day.

What is often missing is not sales skill.

It is structured fluency in how CMS strategy shapes hospital decision making.

Hospitals operate within an economic environment that is heavily influenced by Medicare reimbursement and federal policy.

Mandatory payment models, quality penalties, reimbursement reforms, and price transparency requirements all influence hospital budgets and strategic priorities.

Most sales training was never designed to teach this layer of the healthcare market.

As a result, even experienced sales professionals may be very well prepared to explain how their solution works but less prepared to connect that solution to the financial and policy forces hospital executives are managing.

That is the real opportunity.

When commercial teams develop CMS strategy fluency, they elevate the conversations they already know how to have.

They position solutions within the financial realities hospitals face.

They engage hospital leadership in more strategic discussions.

And they compete less on product features alone.

How Hospital Executives Actually Evaluate Vendors

Most vendors begin conversations by explaining their product.

Hospital executives begin somewhere else entirely.

They start with financial impact.

In practical terms, hospital leaders tend to evaluate vendor solutions through a sequence that looks something like this.

First comes financial impact.

How does this affect hospital margin?
Does it protect reimbursement?
Will it reduce operating costs or avoid financial penalties?

If the financial impact is unclear, the conversation often stops there.

Second comes alignment with reimbursement and policy programs.

Hospital executives want to know how a solution fits within the payment models and regulatory environment shaping their organization.

Third comes operational impact.

Will clinicians adopt the solution?
Will it improve workflow or reduce complications?

Only after those filters are satisfied do most organizations evaluate product specifications, technical details, and vendor comparisons.

Many vendors begin at the bottom of this stack.

Hospital executives begin at the top.

Fluency in healthcare means understanding that difference and structuring conversations accordingly.

The Structural Forces Shaping Hospital Strategy

Hospitals are not simply operating businesses.

They function within a highly structured economic system shaped by federal reimbursement and regulatory policy.

The Centers for Medicare and Medicaid Services, known as CMS, plays a central role in that system.

CMS determines how hospitals get paid for Medicare patients.

It also determines how hospitals are penalized for poor quality performance or excessive costs.

Over the past decade, CMS has increasingly shifted the healthcare system toward value based payment models.

Instead of rewarding volume alone, these models hold hospitals accountable for cost, quality, and patient outcomes.

As these policies expand, they increasingly influence how hospital leaders evaluate investments.

Understanding these policies allows commercial teams to connect their solutions to the strategic priorities hospital executives are managing.

Major CMS Initiatives Reshaping Hospital Decisions

Several major CMS programs are currently influencing hospital strategy and purchasing decisions.

Understanding these initiatives provides important context for anyone selling into hospitals.

The Transforming Episode Accountability Model (TEAM)

One of the most significant recent policy developments is the Transforming Episode Accountability Model, commonly called TEAM.

TEAM is a mandatory payment model launching in 2026 that places hospitals at financial risk for the total cost of care surrounding certain surgical procedures.

Participating hospitals are accountable not only for the surgical procedure itself but also for costs incurred during the thirty days following discharge.

Those costs can include readmissions, post acute care, skilled nursing facility stays, and other services.

If hospitals manage these episodes efficiently and keep costs below CMS targets, they share in savings.

If costs exceed targets, hospitals face financial penalties.

This model fundamentally changes how hospitals evaluate surgical technologies, care coordination tools, and post acute management solutions.

Products that reduce complications, shorten length of stay, or prevent readmissions become financially meaningful under TEAM.

The Hospital Readmissions Reduction Program (HRRP)

Another longstanding and influential program is the Hospital Readmissions Reduction Program.

Under HRRP, hospitals with higher than expected readmission rates for certain conditions can face penalties of up to three percent across all Medicare inpatient payments.

This penalty structure makes readmission reduction a board level priority for many hospitals.

Solutions that improve discharge planning, patient education, medication adherence, and post discharge monitoring can directly influence performance under this program.

Commercial teams that understand HRRP can position their offerings in ways that clearly connect to hospital financial performance.

Hospital Value Based Purchasing

CMS also operates the Hospital Value Based Purchasing Program, often referred to as VBP.

Under this program, two percent of Medicare hospital reimbursement is withheld and then redistributed based on performance across several quality domains.

These domains include clinical outcomes, patient safety, patient experience, and efficiency of care.

Hospitals that perform well receive additional payments.

Hospitals that perform poorly lose the withheld revenue.

Technologies that improve patient safety, infection prevention, clinical outcomes, or patient experience scores often align directly with these incentives.

Understanding the structure of VBP allows vendors to demonstrate how their solutions influence measurable hospital performance metrics.

Hospital Acquired Condition Reduction Program

The Hospital Acquired Condition Reduction Program penalizes hospitals that perform poorly on safety measures such as infection rates and certain patient safety indicators.

Hospitals in the lowest performing quartile lose one percent of all Medicare payments.

Because this penalty applies across all Medicare revenue, the financial impact can be substantial for larger systems.

Solutions that reduce hospital acquired infections, surgical complications, or patient safety events can help hospitals avoid this penalty exposure.

Site Neutral Payment Reform

Another important policy development is site neutral payment reform.

Historically, services performed in hospital outpatient departments were reimbursed at higher rates than the same services provided in physician offices.

CMS has begun reducing these differences.

For many hospitals, this change compresses revenue in outpatient settings.

As margins tighten, hospital leaders often prioritize investments that improve efficiency, reduce costs, or protect profitability.

Understanding these financial pressures helps vendors position solutions that support operational sustainability.

Rural Health Transformation Program

CMS has also introduced the Rural Health Transformation Program, a major federal initiative providing tens of billions of dollars to support rural healthcare infrastructure and operational transformation.

These funds are intended to support technology adoption, workforce development, and innovative care delivery models.

For companies serving rural hospitals, understanding how this program works can reveal funded opportunities for technology and operational investments.

Price Transparency Enforcement

CMS has also strengthened enforcement of hospital price transparency requirements.

Hospitals must now publish detailed information about negotiated rates with insurers and provide consumer friendly pricing data.

The goal is to increase market transparency and encourage price competition.

For vendors, this environment places greater emphasis on clearly articulating value and return on investment.

Hospitals are increasingly scrutinizing costs across their vendor relationships.

Solutions that can demonstrate measurable financial impact tend to stand out.

Why CMS Fluency Matters for Commercial Teams

The reason these programs matter for vendors is straightforward.

Medicare is the largest payer in the United States healthcare system.

The policies that govern Medicare reimbursement shape how hospitals generate revenue, manage risk, and evaluate investments.

Hospital executives consider these factors constantly.

CFOs analyze reimbursement implications.
COOs evaluate operational efficiency.
Chief medical officers focus on quality performance.

When vendors understand these pressures, their conversations become more relevant.

Instead of presenting a product, they connect their solution to a hospital’s financial and strategic priorities.

This shift often leads to stronger executive engagement and more meaningful discussions.

From Product Pitch to Strategic Conversation

In many healthcare sales interactions, the conversation begins with product education.

The vendor explains the technology.

The hospital evaluates features and compares alternatives.

Eventually the discussion turns to price.

But when commercial teams understand the policy and economic environment hospitals operate within, the conversation often begins differently.

It begins with the hospital’s challenges.

How do we reduce readmissions?
How do we manage episode costs under bundled payments?
How do we improve quality scores?
How do we maintain margin in a changing reimbursement environment?

Solutions that clearly address these questions often receive greater attention from hospital leadership.

The vendor is no longer just explaining a product.

They are participating in a strategic discussion about hospital performance.

The Competitive Advantage of Insight

In competitive markets, information alone rarely differentiates vendors.

Every company can present product data and clinical evidence.

Insight connects that information to the problems executives are actively trying to solve.

When a vendor demonstrates an understanding of the reimbursement environment shaping hospital decisions, it signals credibility.

It shows that the company understands the customer’s operating reality.

This type of insight often leads to deeper engagement with hospital leadership and more productive discussions about long term partnership.

The Future of Selling to Hospitals

Healthcare policy will continue evolving.

Payment reform, value based care models, and quality measurement programs will remain central to how hospitals operate.

As these forces expand, the expectations placed on vendors will evolve as well.

Hospital leaders increasingly value partners who understand the economic and regulatory environment shaping their organizations.

They respond to vendors who bring perspective and insight, not just products.

Fluency in healthcare is ultimately about understanding the system hospitals operate within.

Because in the hospital market, understanding the product is important.

Understanding the environment that shapes hospital decisions is what turns that knowledge into strategy.

Fluent in Healthcare Workshop

Fluent in Healthcare is a first of its kind strategic program designed for commercial teams that sell into hospitals and health systems. Developed from more than three decades of experience advising hospital leadership and closing enterprise healthcare deals, the program teaches a capability rarely addressed in traditional sales training: how to interpret CMS policy, reimbursement structures, and hospital financial strategy through a commercial lens.

Participants learn how hospital executives actually evaluate investments, how federal payment initiatives and quality programs shape purchasing decisions, and how to position solutions within the economic forces governing hospital performance. The result is a level of strategic fluency that allows commercial leaders to move beyond product conversations and engage the hospital C suite with insight, credibility, and a deep understanding of the environment in which healthcare decisions are made.

Learn more: https://fluentinhealthcare.com